Dezuo Dong

597 total citations
20 papers, 283 citations indexed

About

Dezuo Dong is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Dezuo Dong has authored 20 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Dezuo Dong's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Esophageal Cancer Research and Treatment (3 papers) and Advanced Radiotherapy Techniques (3 papers). Dezuo Dong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Esophageal Cancer Research and Treatment (3 papers) and Advanced Radiotherapy Techniques (3 papers). Dezuo Dong collaborates with scholars based in China, Ethiopia and United States. Dezuo Dong's co-authors include Weihu Wang, Qimin Zhan, Xianggao Zhu, Yan Wang, Hongzhi Wang, Weimin Zhang, Yongheng Li, Qingnan Wu, Shuai Li and Yong Cai and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.

In The Last Decade

Dezuo Dong

17 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dezuo Dong China 9 122 119 77 60 59 20 283
Shi‐Xun Lu China 12 120 1.0× 109 0.9× 96 1.2× 23 0.4× 53 0.9× 21 277
Akinari Morinaga Japan 10 108 0.9× 87 0.7× 97 1.3× 79 1.3× 68 1.2× 25 312
Yichuan Yuan China 8 68 0.6× 126 1.1× 46 0.6× 93 1.6× 34 0.6× 12 270
Ningyuan Wen China 7 62 0.5× 71 0.6× 63 0.8× 110 1.8× 59 1.0× 22 241
Yunwei Han China 11 135 1.1× 79 0.7× 70 0.9× 65 1.1× 26 0.4× 28 331
Yichuan Yuan China 8 60 0.5× 82 0.7× 62 0.8× 135 2.3× 44 0.7× 20 265
Ziyu Xun China 11 175 1.4× 72 0.6× 94 1.2× 112 1.9× 114 1.9× 35 340
Shujie Pang China 8 52 0.4× 89 0.7× 61 0.8× 22 0.4× 56 0.9× 22 282
Rusi Zhang China 11 44 0.4× 76 0.6× 114 1.5× 43 0.7× 60 1.0× 27 248

Countries citing papers authored by Dezuo Dong

Since Specialization
Citations

This map shows the geographic impact of Dezuo Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dezuo Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dezuo Dong more than expected).

Fields of papers citing papers by Dezuo Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dezuo Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dezuo Dong. The network helps show where Dezuo Dong may publish in the future.

Co-authorship network of co-authors of Dezuo Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Dezuo Dong. A scholar is included among the top collaborators of Dezuo Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dezuo Dong. Dezuo Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Fan, Bo Chen, Dezuo Dong, et al.. (2025). Neoadjuvant versus adjuvant radiotherapy for centrally located hepatocellular carcinoma: a propensity score matching study based on two prospective phase II trials. Therapeutic Advances in Medical Oncology. 17. 22787422–22787422.
3.
Zheng, Xuan, Hongzhi Wang, Dezuo Dong, et al.. (2025). Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 1097–1110.
4.
Wang, Weihu, et al.. (2024). Safety and efficacy of camrelizumab and apatinib in combination with IMRT in unresectable hepatocellular carcinoma: A non-randomised phase 2 study.. Journal of Clinical Oncology. 42(16_suppl). e16157–e16157. 1 indexed citations
5.
Wang, Hongzhi, Xuan Zheng, Jiawen Sun, et al.. (2023). 4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases. Clinical and Translational Radiation Oncology. 45. 100714–100714. 2 indexed citations
6.
Dong, Dezuo, Xianggao Zhu, Hongzhi Wang, et al.. (2022). Prognostic significance of albumin–bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapy. Journal of Medical Imaging and Radiation Oncology. 66(5). 662–670. 7 indexed citations
7.
Wang, Hongzhi, Xianggao Zhu, Yuting Zhao, et al.. (2022). Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma. BMC Cancer. 22(1). 2 indexed citations
8.
Teng, Huajing, Yan Wang, Xin Sui, et al.. (2022). Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell. 41(1). 124–138.e6. 71 indexed citations
9.
Wu, Fan, Bo Chen, Dezuo Dong, et al.. (2022). Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma. JAMA Surgery. 157(12). 1089–1089. 25 indexed citations
10.
Wu, Qingnan, Weimin Zhang, Yan Wang, et al.. (2021). MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma. Cancer Communications. 41(12). 1354–1372. 20 indexed citations
11.
Du, Feng, Dezuo Dong, Xiaodong Zhang, & Jun Jia. (2021). MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 20. 2203794030–2203794030. 5 indexed citations
12.
Dong, Dezuo, et al.. (2021). Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study. British journal of surgery. 108(4). e164–e165. 4 indexed citations
13.
Li, Shuai, Dezuo Dong, Jianhao Geng, et al.. (2021). Stereotactic body radiotherapy prolongs the progression‐free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology. 18(2). e64–e72. 4 indexed citations
14.
Dong, Dezuo, Weimin Zhang, Qingnan Wu, et al.. (2020). A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression. Cancer Research. 81(4). 910–922. 24 indexed citations
15.
Dong, Dezuo, Dan Zhao, Shuai Li, et al.. (2020). Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population study. Annals of Translational Medicine. 8(23). 1588–1588. 8 indexed citations
16.
Li, Shuai, Dezuo Dong, Jianhao Geng, et al.. (2019). Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer. Frontiers in Oncology. 9. 1080–1080. 21 indexed citations
17.
Zhao, Yuting, Xianggao Zhu, Hongzhi Wang, et al.. (2019). Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion. Frontiers in Oncology. 9. 1065–1065. 19 indexed citations
18.
Chen, Xin, Dezuo Dong, Changcun Pan, et al.. (2018). Identification of Grade-associated MicroRNAs in Brainstem Gliomas Based on Microarray Data. Journal of Cancer. 9(23). 4463–4476. 8 indexed citations
19.
Zhang, Weimin, Ruoxi Hong, Lin Li, et al.. (2018). The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment. Molecular Cancer. 17(1). 125–125. 34 indexed citations
20.
Hong, Ruoxi, Liyan Xue, Xiaofang Liu, et al.. (2017). Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma. Oncogene. 36(27). 3890–3902. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shi‐Xun Lu Breakdown of academic impact, for papers by Akinari Morinaga Breakdown of academic impact, for papers by Yichuan Yuan Breakdown of academic impact, for papers by Ningyuan Wen Breakdown of academic impact, for papers by Yunwei Han Breakdown of academic impact, for papers by Yichuan Yuan Breakdown of academic impact, for papers by Ziyu Xun Breakdown of academic impact, for papers by Shujie Pang Breakdown of academic impact, for papers by Rusi Zhang
Rankless by CCL
2026